Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension

Marie Claire Boffa, Luca Valsecchi, Alfonso Fausto, Danielle Gozin, Silvana Vigano'D'angelo, Omid Safa, Maria Teresa Castiglioni, Jean Amiral, Armando D'Angelo

Research output: Contribution to journalArticle

Abstract

In a prospective longitudinal study, 130 primigravidae at risk for preeclampsia were examined and plasma sampling performed in 45 of them. Plasma thrombomodulin (pTM) was sequentially measured at weeks 12, 24 and 32 of gestation and after delivery in 20 primigravidae who developed either mild preeclampsia (n = 8) or gestational hypertension (n = 12) between weeks 32 and 39 of gestation and in 25 (age-matched) primigravidae who had uneventful pregnancies. pTM elevations were not observed until week 32 in uneventful pregnancies, but were present by week 24 (p = 0.002) in patients who later developed hypertensive complications. A net individual pTM increase ≤ 4.2 ng/ml between weeks 12 and 24 (more than 8 times that of normotensive primigravidae) and/or pTM level ≤ 47.5 ng/ml at week 32 predicted the development of hypertensive complications with 80% accuracy. Serial pTM determinations can be useful to select pregnancies who may benefit from early pharmacological intervention.

Original languageEnglish
Pages (from-to)1092-1095
Number of pages4
JournalThrombosis and Haemostasis
Volume79
Issue number6
Publication statusPublished - 1998

Fingerprint

Thrombomodulin
Pregnancy Induced Hypertension
Pre-Eclampsia
Pregnancy
Longitudinal Studies
Prospective Studies
Pharmacology

ASJC Scopus subject areas

  • Hematology

Cite this

Boffa, M. C., Valsecchi, L., Fausto, A., Gozin, D., Vigano'D'angelo, S., Safa, O., ... D'Angelo, A. (1998). Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thrombosis and Haemostasis, 79(6), 1092-1095.

Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. / Boffa, Marie Claire; Valsecchi, Luca; Fausto, Alfonso; Gozin, Danielle; Vigano'D'angelo, Silvana; Safa, Omid; Castiglioni, Maria Teresa; Amiral, Jean; D'Angelo, Armando.

In: Thrombosis and Haemostasis, Vol. 79, No. 6, 1998, p. 1092-1095.

Research output: Contribution to journalArticle

Boffa, MC, Valsecchi, L, Fausto, A, Gozin, D, Vigano'D'angelo, S, Safa, O, Castiglioni, MT, Amiral, J & D'Angelo, A 1998, 'Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension', Thrombosis and Haemostasis, vol. 79, no. 6, pp. 1092-1095.
Boffa MC, Valsecchi L, Fausto A, Gozin D, Vigano'D'angelo S, Safa O et al. Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thrombosis and Haemostasis. 1998;79(6):1092-1095.
Boffa, Marie Claire ; Valsecchi, Luca ; Fausto, Alfonso ; Gozin, Danielle ; Vigano'D'angelo, Silvana ; Safa, Omid ; Castiglioni, Maria Teresa ; Amiral, Jean ; D'Angelo, Armando. / Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. In: Thrombosis and Haemostasis. 1998 ; Vol. 79, No. 6. pp. 1092-1095.
@article{231ff4861dbc47608aaf0fb698de2137,
title = "Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension",
abstract = "In a prospective longitudinal study, 130 primigravidae at risk for preeclampsia were examined and plasma sampling performed in 45 of them. Plasma thrombomodulin (pTM) was sequentially measured at weeks 12, 24 and 32 of gestation and after delivery in 20 primigravidae who developed either mild preeclampsia (n = 8) or gestational hypertension (n = 12) between weeks 32 and 39 of gestation and in 25 (age-matched) primigravidae who had uneventful pregnancies. pTM elevations were not observed until week 32 in uneventful pregnancies, but were present by week 24 (p = 0.002) in patients who later developed hypertensive complications. A net individual pTM increase ≤ 4.2 ng/ml between weeks 12 and 24 (more than 8 times that of normotensive primigravidae) and/or pTM level ≤ 47.5 ng/ml at week 32 predicted the development of hypertensive complications with 80{\%} accuracy. Serial pTM determinations can be useful to select pregnancies who may benefit from early pharmacological intervention.",
author = "Boffa, {Marie Claire} and Luca Valsecchi and Alfonso Fausto and Danielle Gozin and Silvana Vigano'D'angelo and Omid Safa and Castiglioni, {Maria Teresa} and Jean Amiral and Armando D'Angelo",
year = "1998",
language = "English",
volume = "79",
pages = "1092--1095",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "6",

}

TY - JOUR

T1 - Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension

AU - Boffa, Marie Claire

AU - Valsecchi, Luca

AU - Fausto, Alfonso

AU - Gozin, Danielle

AU - Vigano'D'angelo, Silvana

AU - Safa, Omid

AU - Castiglioni, Maria Teresa

AU - Amiral, Jean

AU - D'Angelo, Armando

PY - 1998

Y1 - 1998

N2 - In a prospective longitudinal study, 130 primigravidae at risk for preeclampsia were examined and plasma sampling performed in 45 of them. Plasma thrombomodulin (pTM) was sequentially measured at weeks 12, 24 and 32 of gestation and after delivery in 20 primigravidae who developed either mild preeclampsia (n = 8) or gestational hypertension (n = 12) between weeks 32 and 39 of gestation and in 25 (age-matched) primigravidae who had uneventful pregnancies. pTM elevations were not observed until week 32 in uneventful pregnancies, but were present by week 24 (p = 0.002) in patients who later developed hypertensive complications. A net individual pTM increase ≤ 4.2 ng/ml between weeks 12 and 24 (more than 8 times that of normotensive primigravidae) and/or pTM level ≤ 47.5 ng/ml at week 32 predicted the development of hypertensive complications with 80% accuracy. Serial pTM determinations can be useful to select pregnancies who may benefit from early pharmacological intervention.

AB - In a prospective longitudinal study, 130 primigravidae at risk for preeclampsia were examined and plasma sampling performed in 45 of them. Plasma thrombomodulin (pTM) was sequentially measured at weeks 12, 24 and 32 of gestation and after delivery in 20 primigravidae who developed either mild preeclampsia (n = 8) or gestational hypertension (n = 12) between weeks 32 and 39 of gestation and in 25 (age-matched) primigravidae who had uneventful pregnancies. pTM elevations were not observed until week 32 in uneventful pregnancies, but were present by week 24 (p = 0.002) in patients who later developed hypertensive complications. A net individual pTM increase ≤ 4.2 ng/ml between weeks 12 and 24 (more than 8 times that of normotensive primigravidae) and/or pTM level ≤ 47.5 ng/ml at week 32 predicted the development of hypertensive complications with 80% accuracy. Serial pTM determinations can be useful to select pregnancies who may benefit from early pharmacological intervention.

UR - http://www.scopus.com/inward/record.url?scp=0031833418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031833418&partnerID=8YFLogxK

M3 - Article

C2 - 9657429

AN - SCOPUS:0031833418

VL - 79

SP - 1092

EP - 1095

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 6

ER -